# Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema

> **NCT01119313** · PHASE2 · COMPLETED · sponsor: **Almirall, S.A.** · enrollment: 20 (actual)

## Conditions studied

- Atopic Eczema

## Interventions

- **DRUG:** LAS 41002
- **DRUG:** Active

## Key facts

- **NCT ID:** NCT01119313
- **Lead sponsor:** Almirall, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2010-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01119313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01119313, "Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01119313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*